Phase 2 Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with stomach (gastric) adenocarcinoma confirmed by a tissue test (pathology)
- People whose fluid build-up in the abdomen (ascites) has been confirmed to contain cancer cells through a fluid sample test
- People whose abdominal fluid build-up has been confirmed by a CT scan and is classified as moderate or large in amount (grade 2 or 3)
- People aged between 18 and 75 years
- People who have not received any drugs injected directly into the abdominal cavity, or any immunotherapy treatment, in the past 4 weeks
- People who are in a reasonably stable general condition, with a functional ability score of 70 or above on the Karnofsky scale, and an expected survival of more than 3 months
- People whose blood counts are within acceptable ranges (including red blood cells, white blood cells, and platelets meeting specific minimum levels)
- People whose blood clotting function is normal and who do not have a tendency to bleed (based on a specific clotting test result)
- People whose liver function test results are within acceptable limits
- People whose kidney function test results are within acceptable limits
Who may not be able to join:
- People whose abdominal fluid build-up is caused by something other than cancer (for example, liver disease or infection)
- People who have medical reasons that make immunotherapy unsafe for them (such as long-term steroid use, or a history of radiation-related lung, liver, or bowel damage)
- People with serious heart or lung conditions that could affect treatment
- People with extensive internal scarring in the abdomen, trapped pockets of fluid, a history of bowel obstruction, or cancer that has spread very widely to distant parts of the body in a late-stage setting
- Women who are pregnant, breastfeeding, or planning to become pregnant
- People with very low blood protein levels (albumin below 30 g/L)
- People who are known to have had a serious allergic reaction to the trial drug or similar medicines
- People with other severe ongoing health conditions that, in the treating doctor's judgement, could affect the study results or make participation unsafe
- People who have difficulty with thinking or memory, or who the treating doctor believes are unlikely to follow the treatment plan consistently
- People who are currently participating in another clinical trial, or who have done so within the past 4 weeks
- People who have been diagnosed with another type of cancer in addition to stomach cancer
- People who, in the treating doctor's overall judgement, are not considered suitable for the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Dose-limiting toxicity (DLT) or maximal tolerance dose (MTD) in the Phase Ib stage; Objective response rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.